Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Stryker Corporation
Stryker Corporation News
Stryker Corporation Quantitative Score
About Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Stryker Corporation Earnings & Revenue
Stryker Corporation Financials
Table Compare
Compare SYK metrics with: | |||
---|---|---|---|
Earnings & Growth | SYK | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | SYK | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | SYK | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | SYK | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Stryker Corporation Income
Stryker Corporation Balance Sheet
Stryker Corporation Cash Flow
Stryker Corporation Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
Metrics | Score |
---|---|
Discounted Cash Flows | Buy |
Return on Equity | Buy |
Return on Assets | Strong Buy |
Debt/Equity Ratio | Strong Sell |
Price/Earnings Ratio | Strong Sell |
Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Stryker Corporation Dividends
Yield (TTM) | Dividend (TTM) | |
---|---|---|
Infinity% | 3.2000 |
Payment Date | Dividend | Frequency |
---|---|---|
2024-10-31 | 0.8 | Quarterly |
2024-07-31 | 0.8 | Quarterly |
2024-04-30 | 0.8 | Quarterly |
2024-01-31 | 0.8 | Quarterly |
2023-10-31 | 0.75 | Quarterly |
Stryker Corporation Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Stryker Corporation Executives
Name | Role |
---|---|
Mr. Kevin A. Lobo | Chairman, Chief Executive Officer & President |
Mr. Glenn S. Boehnlein | Vice President & Chief Financial Officer |
Mr. J. Andrew Pierce | Group President of MedSurg & Neurotechnology |
Mr. Spencer S. Stiles | Group President of Orthopaedics & Spine |
Mr. Viju S. Menon | Group President of Global Quality & Operations |
Name | Role | Gender | Date of Birth | Pay |
---|---|---|---|---|
Mr. Kevin A. Lobo | Chairman, Chief Executive Officer & President | Male | 1965 | 5.7M |
Mr. Glenn S. Boehnlein | Vice President & Chief Financial Officer | Male | 1962 | 2.27M |
Mr. J. Andrew Pierce | Group President of MedSurg & Neurotechnology | Male | 1974 | 2.03M |
Mr. Spencer S. Stiles | Group President of Orthopaedics & Spine | Male | 1977 | 2.02M |
Mr. Viju S. Menon | Group President of Global Quality & Operations | Male | 1968 | 1.68M |
Stryker Corporation Insider Trades
Date | 1 Oct |
Name | Stiles Spencer S |
Role | Group President |
Transaction | Disposed |
Type | F-InKind |
Shares | 552 |
Date | 1 Oct |
Name | Pierce James Andrew |
Role | Group President |
Transaction | Disposed |
Type | F-InKind |
Shares | 641 |
Date | 13 Sep |
Name | Fink M Kathryn |
Role | VP, Chief HR Officer |
Transaction | Disposed |
Type | S-Sale |
Shares | 2121 |
Date | 16 Sep |
Name | Fink M Kathryn |
Role | VP, Chief HR Officer |
Transaction | Acquired |
Type | M-Exempt |
Shares | 7347 |
Date | 17 Sep |
Name | Fink M Kathryn |
Role | VP, Chief HR Officer |
Transaction | Disposed |
Type | S-Sale |
Shares | 258 |
Date | Name | Role | Transaction | Type | Shares |
---|---|---|---|---|---|
1 Oct | Stiles Spencer S | Group President | Disposed | F-InKind | 552 |
1 Oct | Pierce James Andrew | Group President | Disposed | F-InKind | 641 |
13 Sep | Fink M Kathryn | VP, Chief HR Officer | Disposed | S-Sale | 2121 |
16 Sep | Fink M Kathryn | VP, Chief HR Officer | Acquired | M-Exempt | 7347 |
17 Sep | Fink M Kathryn | VP, Chief HR Officer | Disposed | S-Sale | 258 |